JACC. Case reports · 2026
Severe Aortic Stenosis and Acute Hip Fracture: An Expedited TAVR-First Pathway.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chowdhury Ishmum, Torrado Juan, Kaushik Sharanya, Echarte-Morales Julio, Leone Pier Pasquale, Sturla Matteo, Assafin Manaf, Sugiura Tadahisa, Scotti Andrea, Latib Azeem
Аннотация
CLINICAL CONDITION: An elderly man presented with severe symptomatic aortic stenosis (AS) and an acute acetabular fracture, representing a high-risk intersection of cardiovascular and orthopedic emergencies.
KEY QUESTIONS: What are the mechanistic and clinical links between AS and hip fracture (HFx)? How should management balance the urgency of fracture fixation with the hemodynamic instability of severe AS? What are the logistical and procedural considerations for performing transcatheter aortic valve replacement (TAVR) in this setting? What antithrombotic strategy should guide periprocedural management? Which complications can be avoided with a structured, multidisciplinary pathway?
OUTCOME: The patient underwent expedited, minimalist transfemoral TAVR under conscious sedation on day 1, followed by HFx repair on day 2. He recovered without complications, was discharged on day 4, and remained fully independent at 1 year with stable valve function and no paravalvular leak.
TAKE-HOME MESSAGES: In carefully selected patients with severe AS and acute HFx managed at TAVR-capable centers, a coordinated, expedited TAVR-first strategy appears feasible and may enable safe, timely orthopedic repair and recovery. Antithrombotic management must be individualized. Multidisciplinary, time-sensitive management is essential, and patient selection remains paramount.
KEY QUESTIONS: What are the mechanistic and clinical links between AS and hip fracture (HFx)? How should management balance the urgency of fracture fixation with the hemodynamic instability of severe AS? What are the logistical and procedural considerations for performing transcatheter aortic valve replacement (TAVR) in this setting? What antithrombotic strategy should guide periprocedural management? Which complications can be avoided with a structured, multidisciplinary pathway?
OUTCOME: The patient underwent expedited, minimalist transfemoral TAVR under conscious sedation on day 1, followed by HFx repair on day 2. He recovered without complications, was discharged on day 4, and remained fully independent at 1 year with stable valve function and no paravalvular leak.
TAKE-HOME MESSAGES: In carefully selected patients with severe AS and acute HFx managed at TAVR-capable centers, a coordinated, expedited TAVR-first strategy appears feasible and may enable safe, timely orthopedic repair and recovery. Antithrombotic management must be individualized. Multidisciplinary, time-sensitive management is essential, and patient selection remains paramount.